Role of procalcitonin in predicting the bowel gangrene and ischemia in acute intestinal obstruction

Harindranath H. R., Praveen K. H., Lakshmi Vijaykumar


Background: Acute intestinal obstruction being the most common presentation on intestinal ischaemia and bowel gangrene. This study mainly concentrated on need for new marker for early prediction mesenteric ischaemia. Procalcitonin as a marker for stoppage of conservative management in intestinal obstruction.  

Methods: Out 70 patients 45 underwent conservative and 25 eventually underwent surgery (midline laparotomy). Procalcitonin levels in both are observed at regular intervals and compared and analysis done using appropriate statistical tests.

Results: Level of procalcitonin was found to be higher in patients who need surgery consistantly when compared with those who were in conservative line of management with mean PCT level 2.19 and 2.23 in conservative line with mean PCT of 3.68 and 6.58 for surgical need at presentation and after 48 hrs respectively with p value <0.0001 which is significant.  

Conclusions: PCT at presentation can be a very good tool for predicting the bowel ischaemia and gangrene as an early indicator and also it can be used as a marker for need for surgery in patients managing conservatively for intestinal obstruction.  


Intestinal obstruction, Serum procalcitonin, Bowel gangrene, C-reactive protein

Full Text:



Meisner M. Pathobiochemistry and clinical use of procalci- tonin. Clin Chim Acta. 2002;323:17-29.

Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341:515-8.

Rau BM, Frigerio I, Bu ̈chler MW, Wegscheider K, Bassi C, Puolakkainen PA, et al. Evaluation of procalcitonin for pre- dicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicen- ter study. Arch Surg. 2007;142:134-42.

Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L. Procalcitonin and C-reactive protein during sys- temic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 2004;8:R234-42.

Mimoz O, Benoist JF, Edouard AR, Assicot M, Bohuon C, Samii K. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syn- drome. Intens Care Med. 1998;24:185-8.

Hensel M, Volk T, Do ̈cke WD, Kern F, Tschirna D, Egerer K, et al. Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopul- monary bypass. Anesthesiology. 1998;89:93-104.

Assicot M, Gendrel D, Carsın H, Raymond J, Guilbaud J, Bohoun C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341(8844):515-8.

Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med. 2011;22(9):107.

Maruna P, Frasko R, Gulrich R. Plasma procalcitonine in patients with ileus. Relations to other inflammatory parameters. Physiol Res. 2008;57(3):481-6.

Meisner M, Schmidt J, Hüttner H, Tschaikowsky K. The natu- ral elimination rate of procalcitonin in patients with normal and impaired renal function. Intensive Care Med 2000;26(2):S212-6.

Stolberg L, Rolfe R, Gitlin N, Merritt J, Mann L, Linder J, Fine- gold S. d-Lactic acidosis due to abnormal gut flora: diagnosis and treatment of two cases. N Engl J Med. 1982;306:1344-8.